Random

psilocybin

Featured Neuroscience Psychology

·January 6, 2022·5 min read

Psilocybin, in 10mg or 25mg Doses, Has No Short- Or Long-Term Detrimental Effects in Healthy People

Study demonstrates the safety and feasibility of psilocybin for the treatment of mental health disorders.

Featured Neuroscience Psychology

·April 11, 2022·5 min read

Psilocybin Increases Brain Connectivity in People With Depression After Use

People with depression who responded to psilocybin therapy showed an increase in brain connectivity for up to three weeks following treatment. The increased brain connectivity was correlated with self-reported improvements in depression symptoms.

Featured Neuroscience Open Neuroscience Articles Psychology

·July 15, 2019·4 min read

Improved mood and focus reported by microdosers

Microdosing, a growing trend where people take small doses for psychedelic drugs, is associated with improved mood, focus, and creativity. For some, microdosing may provide a possible alternative to SSRI antidepressants. However, researchers warn of some potential problems with microdosing, including negative side effects, psychological stigma, and exposure to elicit, black market products.

Featured Neuroscience Psychology

·February 21, 2021·4 min read

From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

From microdosing to improve cognition, to treating a range of mental health disorders, researchers evaluate the rise in the use of psychedelics and their potential as medicines.

Featured Psychology

·November 4, 2020·5 min read

Psychedelic Treatment With Psilocybin Relieves Major Depression

Two doses of psilocybin in combination with therapy rapidly and significantly reduces symptoms in those with major depressive disorder. The effects appear to last for up to four weeks.

Featured Neuroscience Psychology

·May 2, 2023·5 min read

Decoding the Molecular Mechanisms of Psilocybin Mushrooms’ Hallucinogenic Effects

A new study adds to the growing body of evidence suggesting psilocybin, a hallucinogenic compound found in certain mushroom species, could potentially revolutionize the treatment of depression and substance addiction. Researchers focused on the molecular interactions of psilocybin in the brain. The findings may help with designing new drugs that can treat a range of mental health disorders.

Featured Neuroscience Open Neuroscience Articles Psychology

·February 11, 2019·5 min read

Does Microdosing Improve Mood and Performance?

A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing.

Featured Neurology Psychology

·January 23, 2012·4 min read

Magic Mushrooms’ Effects Illuminated in Brain Imaging Studies

Brain scans of people under the influence of the psilocybin, the active ingredient in magic mushrooms, have given scientists the...

Featured Neuroscience Psychology

·September 1, 2022·4 min read

Most Promising PTSD Treatment May Use ‘Ecstasy’ or ‘Magic Mushrooms’ Alongside Psychotherapy

Prescribing psychedelic therapies including MDMA and psilocybin in combination with counseling and psychotherapy improve symptoms for those with PTSD.

Featured Neuroscience Psychology

·October 3, 2023·5 min read

Psilocybin Microdosing Promising for Mental Health Disorders

Researchers delve into the therapeutic potential of psilocybin microdosing, exploring its influence on stress resilience and compulsive behaviors in rats. While high-dose psilocybin therapy has been scrutinized for psychiatric treatment applications, this study focuses on low, repeated doses—commonly known as 'microdosing'—and its burgeoning popularity in self-medication narratives online.

This shows a psychedelic face and flowers

Featured Neuroscience Psychology

·January 28, 2020·5 min read

Could psychedelics help treat mental health and resolve the climate crisis?

Numerous recent studies claim psychedelics, such as psilocybin, can help treat a range of mental health problems from depression to PTSD. Researchers investigate how psychedelics can help us become more "nature-connected" and increase a sense of environmental responsibility.

Featured Neuroscience Open Neuroscience Articles

·February 27, 2018·3 min read

Why Are Some Mushrooms “Magic”?

Researchers investigate the evolutionary development of psilocybin in some mushrooms. They conclude mushrooms may have evolved to be hallucinogenic to lower the odds of being eaten by insects.

1 2 3 … 6

psilocybin

Psilocybin, in 10mg or 25mg Doses, Has No Short- Or Long-Term Detrimental Effects in Healthy People

Psilocybin Increases Brain Connectivity in People With Depression After Use

Improved mood and focus reported by microdosers

From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

Psychedelic Treatment With Psilocybin Relieves Major Depression

Decoding the Molecular Mechanisms of Psilocybin Mushrooms’ Hallucinogenic Effects

Does Microdosing Improve Mood and Performance?

Magic Mushrooms’ Effects Illuminated in Brain Imaging Studies

Most Promising PTSD Treatment May Use ‘Ecstasy’ or ‘Magic Mushrooms’ Alongside Psychotherapy

Psilocybin Microdosing Promising for Mental Health Disorders

Could psychedelics help treat mental health and resolve the climate crisis?

Why Are Some Mushrooms “Magic”?

The Role of Protein Misfolding in Neurodegenerative Diseases

Link Between High Blood Pressure, Immune System, and Cognitive Decline Revealed

Optimism Linked to Poor Decision-Making and Lower Cognitive Skills

Human Brain Development: Growth After Birth Challenges Previous Assumptions

Subscribe